RankingsPricing
  1. US-listed companies
  2. ACURA PHARMACEUTICALS, INC
  3. Raw

ACURA PHARMACEUTICALS, INCACUR

Market cap
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2011		Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021
Net loss-----------1
Depreciation-------0000
Share-based Compensation, Total22111100000
Amortization of intangible asset---00000000
Amortization of right of use asset----------0
Impairment charge on intangible asset---------10
Sales return liability------00-0-
Gains on forgiveness of loans under CARES Act-----------1
Royalty receivable-----000-0-0-
Collaboration revenue receivable from related party-----0-0-00-0
License fee receivable from related party---------0-0
Prepaid expenses and other current assets0-00-0-0-00-0-000
Income taxes refundable00-0---0--0--
Accounts payable01-1-0-0-0-01-0-00
Accrued expenses-0-000-000-0-00-0
Accrued interest on related party loans-------0000
Other current liabilities------000000
Net cash used in operating activities12-7-14----5-4-1-1-1
Proceeds from distribution of RSU awards-------0000
Statutory minimum payroll withholding taxes paid on the distribution of shares pursuant to RSU awards2111-----00
Proceeds from Short-term Debt---------00
Proceeds from Related Party Debt-------41-0
Payments on finance lease----------0
Net cash provided by financing activities-1-112---12100
Net decrease in cash--------21-0-0
Interest Paid, Net------01---